Urgent need for a new staging system in advanced colorectal cancer, J Clin Oncol, vol.26, pp.4828-4861, 2008. ,
Prognostic and predictive response factors in colorectal cancer patients: between hope and reality, World J Gastroenterol, vol.20, pp.15049-59, 2014. ,
Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors, Clin Epidemiol, vol.4, pp.283-301, 2012. ,
Circulating tumor DNA as a liquid biopsy for cancer, Clin Chem, vol.61, pp.112-135, 2015. ,
Liquid biopsy: monitoring cancer-genetics in the blood, Nat Rev Clin Oncol, vol.10, pp.472-84, 2013. ,
Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci Transl Med, vol.6, pp.224-248, 2014. ,
The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC, Br J Cancer, vol.110, pp.363-371, 2014. ,
Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan, Clin Cancer Res, vol.18, pp.1177-85, 2012. ,
Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer, Int J Cancer, vol.135, pp.2984-91, 2014. ,
Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med, vol.368, pp.1199-209, 2013. ,
Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer, J Thorac Oncol, vol.6, pp.286-90, 2011. ,
Circulating free DNA concentration is an independent prognostic biomarker in lung cancer, Eur Respir J, vol.46, pp.1773-80, 2015. ,
Multimarker circulating DNA assay for assessing blood of prostate cancer patients, Clin Chem, vol.55, pp.559-67, 2009. ,
High levels of cellfree circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival, Cancer Invest, vol.33, pp.78-85, 2015. ,
MultiPurpose utility of circulating plasma DNA testing in patients with Advanced Cancers, PLoS ONE, vol.7, p.47020, 2012. ,
Cell-free DNA in the blood as a solid tumor biomarker-a critical appraisal of the literature, Clin Chim Acta, vol.411, pp.1611-1635, 2010. ,
Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer, Future Oncol, vol.7, pp.1385-97, 2011. ,
Prognostic role of methylated free circulating DNA in colorectal cancer, Int J Cancer, vol.131, pp.2308-2327, 2012. ,
Circulating methylated septin 9 nucleic acid in the plasma of patients with gastrointestinal cancer in the stomach and colon, Transl Oncol, vol.6, pp.290-296, 2013. ,
Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients, Mutat Res, vol.778, pp.46-51, 2015. ,
Prediction of breast tumor progression by integrity of free circulating DNA in serum, J Clin Oncol, vol.24, p.4270, 2006. ,
Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients, Clin Cancer Res, vol.14, pp.4141-4146, 2008. ,
Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer, Springerplus, vol.4, p.265, 2015. ,
Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer, Mol Oncol, vol.8, pp.927-968, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01076572
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA, Nat Med, vol.20, pp.430-435, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-02168071
Circulating cell free DNA: preanalytical considerations, Clin Chim Acta, vol.424, pp.222-252, 2013. ,
BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis, PLoS ONE, vol.9, p.90607, 2014. ,
Analysis of circulating tumor DNA to monitor metastatic breast cancer, N Engl J Med, vol.368, pp.1199-209, 2013. ,
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma, Int J Cancer, vol.134, pp.1207-1220, 2014. ,
Telomerase RNA as a detection marker in the serum of breast cancer patients, Clin Cancer Res, vol.6, pp.3823-3829, 2000. ,
KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers, Br J Cancer, vol.108, pp.1757-64, 2013. ,
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer, Cancer Res, vol.66, pp.3992-3997, 2006. ,
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts, Nucleic Acids Res, vol.38, pp.6159-75, 2010. ,
Serial assessment of human tumor burdens in mice by the analysis of circulating DNA, Cancer Res, vol.67, pp.9364-70, 2007. ,
Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load, Transl Oncol, vol.6, pp.319-347, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00872683
High fragmentation characterizes tumour-derived circulating DNA, PLoS ONE, vol.6, 2011. ,
The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients, Br J Cancer, vol.102, pp.1519-1542, 2010. ,
Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value, PLoS Med, vol.10, p.1001453, 2013. ,
A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients, Clin Drug Investig, vol.32, pp.179-87, 2012. ,
Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patients, Resuscitation, vol.83, pp.213-221, 2012. ,
Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location, Ann Intern Med, vol.113, pp.779-88, 1990. ,
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17, Eur J Cancer, vol.51, pp.1405-1419, 2015. ,